MedPath

Clinical study of Prevention and Actual situation of Venous Thromboembolism after Total Arthroplasty

Not Applicable
Conditions
Venous Thromboembolism Osteoarthrosis
Registration Number
JPRN-UMIN000001366
Lead Sponsor
ational Hospital Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
1400
Inclusion Criteria

Not provided

Exclusion Criteria

1.A patient with the past of the blood dyscrasia(a ProteinC,S,AT-3 deficiency disease,an antiphosphatide antibody syndrome,hemophilia)with the solldification abnormality. 2.A atient having tha hemorrhagic mental change caused by a disease(tha hemorrhagic mental changes caused by a disease of the important internalorgans such as a digestive ulcer,the bleeding in the skull). 3.Heart failure(NYHA classification ciass 3 or 4) 4.Renal insufficiency(less than 30ml/min creatinine clearance) 5.Liver function disorder(more than AST institution standard upper limit 5 times or more than 3 times of the ALT upper limit and total bilirubin,more than 2 times of the upper limit). 6.The patient who plan to have simultaneous Total joint anthroplasty for both side. 7.The patient that Total joint arthroplasty was enforced within the past three months,or revisit. 8.The patient whom the chief physician recognizes as inappropriateness for this study participation. 9.The patient who tries artificial feeding(tubal feeding,central vein nourishment). 10.The patient who is not able to walk.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The DVT that was confirmed by sonography of Day10(No symptom characteristics). DVT/PE symptom that broke out by Day25.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath